Impact of KRAS mutation on non-small cell lung cancer survival outcomes

被引：0
|
作者：
Thomas, Q. [1 ]
Lemercier, P. [2 ]
Justeau, G. [3 ]
Schneider, S. [4 ]
Filleron, T. [5 ]
Masip, J. Remon [6 ]
Perol, M. [7 ]
Girard, N. [8 ]
Debieuvre, D. [9 ]
Valette, C. Audigier [10 ]
Chouaid, C. [11 ]
Loeb, A. [12 ]
Hiret, S. [13 ]
Clement-Duchene, C. [14 ]
Dansin, E. [15 ]
Stancu, A. T. [16 ]
Dubray-Longeras, P. [17 ]
Pichon, E. [18 ]
Bosquet, L. [19 ]
Quantin, X. [1 ]
机构：
[1] ICM Inst Canc Montpellier, Dept Oncol, Montpellier, France
[2] ICM Inst Canc Montpellier, Biometr Unit, Montpellier, France
[3] CHU Angers, Pneumol, Angers, France
[4] Ctr Hosp Cote Basque, Pyrenees Atlant, Bayonne, France
[5] IUCT Oncopole, Haute Garonne, Inst Claudius Regaud, Toulouse, France
[6] Inst Gustave Roussy, Dept Oncol, Villejuif, France
[7] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[8] Thorax Inst, Inst Curie, Paris, France
[9] GHRMSA, Pneumol, Mulhouse, France
[10] Hop Sainte Musse, Pneumol, Toulon, France
[11] CH Intercommunal Creteil, Pneumol, Creteil, France
[12] Ctr Henri Becquerel, Pneumol, Rouen, France
[13] ICO Inst Cancerol IOuest Rene Gauducheau, Dept Oncol, St Herblain, France
[14] Inst Cancerol Lorraine Alexis Vautrin, Dept Oncol, Vandoeuvre Les Nancy, France
[15] Ctr Oscar Lambret, Dept Oncol, Lille, France
[16] Inst Sainte Catherine, Pneumol, Avignon, France
[17] Ctr Jean Perrin, Pneumol, Clermont Ferrand, France
[18] CHRU Hop Tours, Pneumol, Hop Bretonneau, Tours, France
[19] UNICANCER, Real World Data, Paris, France
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2433
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1401P
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [41] The impact and role of EGFR gene mutation on non-small cell lung cancer
    Toyooka, Shinichi
    Soh, Junichi
    Shigematsu, Hisayuki
    Aoe, Motoi
    Date, Hiroshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (Suppl 1) : S25 - S31
  • [42] Multiplex in situ immunoprofiling and survival outcomes in non-small cell lung cancer
    Lin, Steven H.
    Mansfield, James R.
    Rao, Xiayu
    Jiang, Wen
    Fang, Penny
    Roman, Kristin
    Wang, Chichung
    Komaki, Ritsuko
    Hahn, Stephen
    Swisher, Stephen G.
    Fujimoto, Junya
    Wistuba, Ignacio
    Wang, Jing
    Hoyt, Clifford C.
    CANCER RESEARCH, 2016, 76
  • [43] Survival outcomes of palliative thoracic radiotherapy in non-small cell lung cancer
    Merrick, Christopher
    Tough, Fay
    LUNG CANCER, 2022, 165 : S59 - S59
  • [44] Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Ohara, Gen
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2009, 29 (07) : 2671 - 2674
  • [45] Implications of KRAS Mutations on Outcomes in Non-small Cell Lung Cancer Treated With Radiation Therapy
    Welsh, J. W.
    Likacheva, A.
    Byers, L. A.
    Bhardwaj, V.
    Diao, L.
    Wang, J.
    Ang, K.
    Komaki, R.
    Kim, E.
    Heymach, J. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S70 - S70
  • [46] The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation
    Duygulu, Mustafa Emre
    Yildirim, Atila
    Ayas, Eyyup
    Alyildiz, Nese
    Mungan, Sevdegul Aydin
    Fidan, Evren
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024, 45 (02) : 127 - 133
  • [47] Clinical characteristics of KRAS mutation subtypes in non-small cell lung cancer population in Xinjiang, China, and their impact on the prognosis of immunotherapy
    Gu, Guomin
    Liu, Chunling
    Zhu, Xiaodan
    Yang, Yan
    Song, Shuming
    Zhao, Yan
    Sun, Gang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (09)
  • [48] Association of Mutation Profiles with Postoperative Survival in Patients with Non-Small Cell Lung Cancer
    Goto, Taichiro
    Kunimasa, Kei
    Hirotsu, Yosuke
    Nakagomi, Takahiro
    Yokoyama, Yujiro
    Higuchi, Rumi
    Otake, Sotaro
    Oyama, Toshio
    Amemiya, Kenji
    Mochizuki, Hitoshi
    Omata, Masao
    CANCERS, 2020, 12 (11) : 1 - 16
  • [49] TP53 mutation, allelism and survival in non-small cell lung cancer
    Nelson, HH
    Wilkojmen, M
    Marsit, CJ
    Kelsey, KT
    CARCINOGENESIS, 2005, 26 (10) : 1770 - 1773
  • [50] Association of Mutation Profiles with Postoperative Survival in Patients with Non-Small Cell Lung Cancer
    Goto, Taichiro
    Hirotsu, Yosuke
    Amemiya, Kenji
    Mochizuki, Hitoshi
    Omata, Masao
    CANCER SCIENCE, 2021, 112 : 653 - 653
12345